Wealthspire Advisors LLC Decreases Stock Holdings in CME Group Inc. (NASDAQ:CME)

Wealthspire Advisors LLC reduced its holdings in CME Group Inc. (NASDAQ:CME) by 0.6% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 162,348 shares of the financial services provider’s stock after selling 992 shares during the period. Wealthspire Advisors LLC’s holdings in CME Group were worth $31,918,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in CME. Aveo Capital Partners LLC bought a new stake in CME Group during the fourth quarter worth approximately $226,000. 9258 Wealth Management LLC increased its position in shares of CME Group by 3.7% during the 4th quarter. 9258 Wealth Management LLC now owns 3,148 shares of the financial services provider’s stock valued at $663,000 after purchasing an additional 113 shares during the last quarter. Gryphon Financial Partners LLC bought a new stake in CME Group in the fourth quarter worth $547,000. Avantax Advisory Services Inc. boosted its stake in CME Group by 2.0% during the fourth quarter. Avantax Advisory Services Inc. now owns 7,097 shares of the financial services provider’s stock worth $1,495,000 after buying an additional 141 shares during the period. Finally, Quadrant Capital Group LLC increased its position in CME Group by 9.7% during the fourth quarter. Quadrant Capital Group LLC now owns 3,711 shares of the financial services provider’s stock valued at $782,000 after acquiring an additional 328 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the company. JPMorgan Chase & Co. boosted their price target on CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a report on Thursday, July 25th. Deutsche Bank Aktiengesellschaft increased their price target on CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a research report on Thursday, August 15th. Bank of America downgraded CME Group from a “neutral” rating to an “underperform” rating and decreased their price objective for the company from $212.00 to $177.00 in a report on Tuesday, September 3rd. Barclays increased their target price on shares of CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a report on Thursday, July 25th. Finally, Piper Sandler restated an “overweight” rating and issued a $225.00 price target on shares of CME Group in a report on Tuesday, August 20th. Four analysts have rated the stock with a sell rating, five have issued a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $209.73.

CME Group Stock Down 0.1 %

Shares of CME Group stock opened at $216.99 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10. The company has a market cap of $78.13 billion, a P/E ratio of 24.69, a PEG ratio of 8.85 and a beta of 0.55. The firm’s 50 day moving average price is $205.69 and its 200-day moving average price is $207.67. CME Group Inc. has a 52-week low of $190.70 and a 52-week high of $223.80.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, beating analysts’ consensus estimates of $2.53 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The company had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.53 billion. During the same period last year, the business posted $2.30 earnings per share. The firm’s revenue was up 12.7% compared to the same quarter last year. On average, sell-side analysts predict that CME Group Inc. will post 9.94 EPS for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th will be issued a $1.15 dividend. The ex-dividend date is Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.12%. CME Group’s dividend payout ratio is currently 52.33%.

Insider Transactions at CME Group

In related news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. The sale was disclosed in a filing with the SEC, which is available through this link. Insiders own 0.30% of the company’s stock.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.